| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 02/03/2000 | CA2335341A1 Peptide analogues of pacap |
| 02/02/2000 | EP0976732A1 1,4-substituted cyclic amine derivatives |
| 02/02/2000 | EP0975599A1 Subtituted isoquinolines as ultra short acting neuromuscular blockers |
| 02/02/2000 | CN1243439A Use of prumipexole in the treating of restless legs syndrome |
| 02/01/2000 | US6020356 Pharmaceutical composition for the treatment of autoimmune diseases |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/26/2000 | EP0973890A2 Secreted proteins and polynucleotides encoding them |
| 01/26/2000 | EP0973731A1 Hydroxamic acid derivatives |
| 01/25/2000 | CA2117466C Application of 2-amino 6-trifluoromethoxy benzothiazole for obtaining a drug useful in the treatment of motor neuron diseases |
| 01/20/2000 | WO2000002870A1 Antiviral macrocyclic compounds |
| 01/20/2000 | WO2000002577A1 Therapeutic use of uncoupling protein hhfcw60 |
| 01/19/2000 | EP0972041A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
| 01/19/2000 | EP0971952A2 Diagnosis method and reagents |
| 01/19/2000 | EP0971898A1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 01/19/2000 | EP0971897A1 Anti-convulsant isoquinolyl-benzamide derivatives |
| 01/19/2000 | EP0971880A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015678 Method for detection of a polynucleotide encoding protein kinase C inhibitor-homolog |
| 01/18/2000 | CA2132954C Modified ciliary neurotrophic factors |
| 01/13/2000 | WO2000001851A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | WO2000001676A1 Potassium channel blocking agents |
| 01/13/2000 | CA2332699A1 Antisense oligonucleotides targeted to il-15 |
| 01/12/2000 | EP0970121A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
| 01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970109A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970043A1 Compounds consisting in particular of effectors of the central nervous system receptors sensitive to excitatory amino acids, preparation and biological applications |
| 01/12/2000 | EP0969875A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 01/12/2000 | EP0969865A1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 01/12/2000 | EP0941224A4 Multivalent salts of pyridostigmine and related compounds |
| 01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/05/2000 | EP0968226A1 G-rich oligo aptamers and methods of modulating an immune response |
| 01/05/2000 | EP0968190A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 01/05/2000 | EP0967892A1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive |
| 01/04/2000 | CA2194103C Polypeptides useful as calcium channel blockers |
| 12/29/1999 | WO1999067395A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 12/29/1999 | WO1999067363A1 Ependymal neural stem cells and method for their isolation |
| 12/29/1999 | WO1999067244A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | EP0938477A4 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 12/29/1999 | EP0625048B1 Synthesis of human procollagens and collagens in recombinant dna systems |
| 12/29/1999 | CA2335193A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
| 12/29/1999 | CA2331923A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 12/29/1999 | CA2330175A1 Ependymal neural stem cells and method for their isolation |
| 12/29/1999 | CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/23/1999 | WO1999065903A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
| 12/23/1999 | WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 12/23/1999 | WO1999065484A1 New use |
| 12/23/1999 | WO1999065478A1 Therapeutic compositions and methods of use |
| 12/23/1999 | DE19827640A1 New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction |
| 12/23/1999 | CA2334900A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
| 12/23/1999 | CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 12/21/1999 | US6004937 Treating muscular and nervous system disorders |
| 12/16/1999 | WO1999064415A1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 12/16/1999 | WO1999064400A1 INHIBITORS OF p38 |
| 12/16/1999 | WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 12/16/1999 | WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064052A1 Novel leukotriene receptor antagonists and their uses |
| 12/16/1999 | WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 12/16/1999 | WO1999064041A1 Multibinding agents that modulate nmda receptors |
| 12/16/1999 | WO1999064038A1 Novel analgesic agents |
| 12/16/1999 | WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors |
| 12/16/1999 | WO1999063999A1 H1-histamine receptor antagonists |
| 12/16/1999 | WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 12/16/1999 | WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors |
| 12/16/1999 | WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 12/16/1999 | WO1999063974A2 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues |
| 12/16/1999 | WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors |
| 12/16/1999 | WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors |
| 12/16/1999 | WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 12/16/1999 | WO1999063930A2 Novel angiotensin receptor modulators and their uses |
| 12/16/1999 | WO1999054280B1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 12/16/1999 | WO1999043807A3 Human channel-related molecules |
| 12/16/1999 | CA2768882A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 12/16/1999 | CA2768841A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 12/16/1999 | CA2768828A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 12/16/1999 | CA2768773A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 12/16/1999 | CA2768682A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 12/16/1999 | CA2321273A1 Novel analgesic agents |
| 12/16/1999 | CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors |
| 12/16/1999 | CA2321152A1 Novel therapeutic agents that modulate endothelin receptors |
| 12/16/1999 | CA2321120A1 .beta.3-adrenergic receptor agonists |
| 12/16/1999 | CA2320926A1 Novel leukotriene receptor antagonists and their uses |
| 12/16/1999 | CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 12/16/1999 | CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 12/16/1999 | CA2319651A1 H1-histamine receptor antagonists |
| 12/16/1999 | CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 12/16/1999 | CA2319497A1 Novel therapeutic agents that modulate estrogen receptors |
| 12/16/1999 | CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 12/16/1999 | CA2319175A1 Multibinding agents that modulate nmda receptors |
| 12/16/1999 | CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors |
| 12/16/1999 | CA2319068A1 Novel angiotensin receptor modulators and their uses |
| 12/16/1999 | CA2318894A1 .beta.2-adrenergic receptor agonists |
| 12/16/1999 | CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors |
| 12/16/1999 | CA2318055A1 .beta.2-adrenergic receptor agonists |
| 12/15/1999 | CN1238761A Benzamidoaldehydes and their use as cryteine protease inhibitors |